The trial enrolled 80 women aged 45 and older diagnosed with breast cancer who were about to start neoadjuvant chemotherapy (NCT), a type of chemo given before surgery to shrink tumors. Participants were randomly assigned to receive either 2,000 IU of vitamin D daily or a placebo for six months, during their chemotherapy treatment.
Similar Posts
Links – Healthcare Economist
Hatch Waxman turns 40. FDA: Integrating RCT into routine clinical practice. Cost of care under Medicare…
Why Nutrition Is Essential for Nurses – Rosanna Davison Nutrition
Nutrition, being a cornerstone of health and wellness, is critical in patient care and personal well-being….
Trump Strategy to Rein In Drug Prices Revives ‘Most Favored Nation’ Plan of His First Term
President Trump’s latest strategy to tackle high drug prices aims to tie the price of U.S….
Lyra Health Expands Substance Use Disorder Support – MedCity News
Lyra Health, a mental health company, announced Monday that it is expanding its substance use disorder…
Why Pfizer Is Dipping Into DTC Telehealth With PfizerForAll – MedCity News
Biopharmaceutical company Pfizer is starting to serve consumers directly through its new telehealth platform called PfizerForAll,…
Spicy Sweet Corn Dill Pickle Dip
Super creamy, tangy, and spicy sweet, this Spicy Sweet Corn Dill Pickle Dip with jalapeños and…
